Comparison of the LDL-receptor binding of VLDL and LDL from apoE4 and apoE3 homozygotes

被引:57
作者
Mamotte, CDS
Sturm, M
Foo, JI
Van Bockxmeer, FM
Taylor, RR
机构
[1] Royal Perth Hosp, Dept Biochem, Perth, WA 6001, Australia
[2] Royal Perth Hosp, Dept Cardiol & Med, Perth, WA 6001, Australia
来源
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM | 1999年 / 276卷 / 03期
关键词
apolipoprotein E genotype; fibroblasts; Hep G2 cells;
D O I
10.1152/ajpendo.1999.276.3.E553
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Compared with apolipoprotein E3 (apoE3), apoE2 is less effective in mediating the binding of lipoproteins to the low-density lipoprotein (LDL) receptor. The influence of the E4 isoform, which is associated with adverse effects on plasma lipids and coronary heart disease, is less clear. We compared the ability of very low density lipoprotein (VLDL) and LDL from paired E4/4 and E3/3 subjects to compete against I-125-labeled LDL for binding with the LDL receptor on cultured fibroblasts and Hep G2 cells. The concentrations of VLDL or LDL required to inhibit binding of I-125-LDL by 50% (IC50, mu g apoB/ml) were determined, and results were assessed in terms of an IC50 ratio, E4/4 IC50 relative to E3/3 IC50, to reduce the influence of interassay variability. In Hep G2 cells, E4/4 VLDL was more effective than E3/3 VLDL in competing for the LDL receptor, the IC50 ratio being lower than unity (0.73 +/- 0.31, P < 0.05, two-tailed t-test). IC50 values themselves were marginally lower in E4/4 than E3/3 subjects (3.7 +/- 1.3 vs. 6.1 +/- 3.7, P < 0.08). However, there was no difference between E4/4 and E3/3 VLDL in competing for the LDL receptor on fibroblasts or between E4/4 and E3/3 LDL in competing for the LDL receptor on either cell type. These results suggest that inheritance of apoE4 is associated with an increased affinity of VLDL particles for LDL receptors on hepatocytes and may partly explain the influence of the E4 isoform on lipid metabolism.
引用
收藏
页码:E553 / E557
页数:5
相关论文
共 27 条
  • [1] ARNOLD KS, 1993, CIRCULATION, V88, P321
  • [2] METABOLISM OF VERY LOW-DENSITY LIPOPROTEIN PROTEINS .1. PRELIMINARY IN-VITRO AND IN-VIVO OBSERVATIONS
    BILHEIMER, DW
    LEVY, RI
    EISENBERG, S
    [J]. BIOCHIMICA ET BIOPHYSICA ACTA, 1972, 260 (02) : 212 - +
  • [3] BOERWINKLE E, 1988, AM J HUM GENET, V42, P104
  • [4] BOERWINKLE E, 1994, AM J HUM GENET, V54, P341
  • [5] Bohnet K, 1996, J LIPID RES, V37, P1316
  • [6] CHAPPELL DA, 1991, J BIOL CHEM, V266, P19296
  • [7] CHAPPELL DA, 1993, J BIOL CHEM, V268, P25487
  • [8] INFLUENCE OF APOLIPOPROTEIN-E POLYMORPHISM ON APOLIPOPROTEIN-B-100 METABOLISM IN NORMOLIPEMIC SUBJECTS
    DEMANT, T
    BEDFORD, D
    PACKARD, CJ
    SHEPHERD, J
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1991, 88 (05) : 1490 - 1501
  • [9] EDELSTEIN C, 1986, METHOD ENZYMOL, V128, P151
  • [10] ABNORMAL SUPPRESSION OF 3-HYDROXY-3-METHYLGLUTARYL-COA REDUCTASE-ACTIVITY IN CULTURED HUMAN-FIBROBLASTS BY HYPERTRIGLYCERIDEMIC VERY LOW-DENSITY LIPOPROTEIN SUBCLASSES
    GIANTURCO, SH
    PACKARD, CJ
    SHEPHERD, J
    SMITH, LC
    CATAPANO, AL
    SYBERS, HD
    GOTTO, AM
    [J]. LIPIDS, 1980, 15 (06) : 456 - 463